Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Christopher Byers, DVM, delivered a session on CKD in cats at the 2025 Fetch Charlotte conference in North Carolina ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Surendra Kumar Sahoo was just 27 years old when he discovered that he was suffering from end-stage renal disease, which meant ...

Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Lifestyle changes play a significant role in preventing CKD. Small changes, like reducing salt intake and staying active, can ...

The impact of chronic kidney disease (CKD) keeps escalating around the world, and this burden is projected to rise with ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia Therapeutics’ endgame remains focused on pushing the therapy into a wide | ...

Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse ...